Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.

Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...

Among 91 women, those who used a closed-loop insulin delivery system spent an average of 65.4% of time in pregnancy-specific ...

The 2025 NCAA football season continues with Week 8, which will see Ole Miss vs. Oklahoma, Texas A&M vs. LSU and more. With ESPN’s newly revamped streaming service now in the mix, watching college ...

With over 2,000 exhibiting plans, 500 speakers and 20 international pavilions, the event reflects Saudi Arabia’s growing ...

The Global Diabetes Devices Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6% by 2026. Key drivers of this growth include the rising incidence of diabetes, ...

Homeowners want every day to feel like a special occasion. A new study has found the average homeowner waits nearly three decades before breaking out special occasion items — so what’s stopping them?

The Rise of Medical-Grade Wearables As we advance further into the 21st century, the intersection of technology and healthcare has become increasingly pronounced. Medical-grade wearables have emerged ...

Having trouble completing the Adrenaline Injector Kills challenge in Battlefield 6? Here is how to get the kills with ease.

Bullish option flow detected in DexCom (DXCM) with 4,618 calls trading, 1.3x expected, and implied vol increasing almost 3 points to 63.76%.